Lockheed Martin stock plunges over 9% after $1.6bn program losses derail Q2 profits

Lockheed Martin Corporation (NYSE: LMT) shares plunged by more than 9% in intraday trading on July 22, 2025, after the American aerospace and defense manufacturer posted a sharp earnings miss due to substantial program losses. The stock was trading at $418.88, falling $41.65 from its previous close of $460.53, marking its steepest one-day percentage decline in over three years. Investors appeared rattled by deteriorating program execution, weaker cash generation, and a significant downward revision to earnings guidance, even as the defense giant reaffirmed its full-year sales outlook.

For the second quarter ended June 29, 2025, Lockheed Martin reported sales of $18.2 billion, compared to $18.1 billion a year earlier. Net earnings dropped to $342 million, or $1.46 per share, from $1.6 billion, or $6.85 per share, in 2Q24. The decline reflected $1.6 billion in pre-tax program losses and an additional $169 million in charges, which together shaved $5.83 per share from earnings. Cash from operations fell to $201 million from $1.9 billion a year ago, and free cash flow turned negative at $150 million, compared to $1.5 billion in the prior-year quarter.

What program losses drove Lockheed Martin’s Q2 earnings collapse, and how are they impacting investor confidence?

Lockheed Martin’s Aeronautics and Rotary and Mission Systems (RMS) units accounted for nearly all of the losses, prompting sharp criticism from institutional investors who have long viewed the company as a benchmark for disciplined program management.

In the Aeronautics segment, a classified program suffered from continued design, integration, and testing challenges, prompting a $950 million reach-forward loss. The program’s revised cost estimates and schedule updates drove Aeronautics’ operating profit to a negative $98 million, compared to $751 million in the same quarter last year. The segment’s operating margin swung to -1.3%, a sharp reversal from the 10.3% margin in 2Q24.

The RMS business posted additional charges totaling $665 million, with $570 million tied to the Canadian Maritime Helicopter Program (CMHP) and $95 million to the Turkish Utility Helicopter Program (TUHP). Lockheed Martin revised cost and sales estimates on these contracts due to renegotiations on expanded mission capabilities, logistical support, and fleet life-extension requirements. RMS sales fell 12% to $3.99 billion, and its operating margin dropped to -4.3% from 10.9% a year earlier.

Institutional investors, according to market commentary, are concerned that repeated execution lapses on legacy programs are undermining Lockheed Martin’s reputation for operational discipline. Some analysts suggested that the Aeronautics losses, particularly on classified work, reflect deeper risk management weaknesses that could influence long-term contract wins.

Despite these setbacks, certain business units delivered solid performance. The Missiles and Fire Control (MFC) segment grew sales by 11% to $3.43 billion, supported by production ramp-ups on the Joint Air-to-Surface Standoff Missile (JASSM), Long Range Anti-Ship Missile (LRASM), and precision fires programs. Operating profit rose to $479 million, with a healthy 14% operating margin, highlighting robust demand for precision strike capabilities amid heightened global security tensions.

The Space segment also posted year-over-year growth, with sales increasing 4% to $3.3 billion, driven by higher volumes on commercial civil space programs, including Orion, and missile defense systems like the Next Generation Interceptor (NGI). Space operating profit improved to $362 million, with margins inching up to 10.9%.

How does Lockheed Martin’s revised financial guidance shape market expectations for the rest of 2025?

Lockheed Martin reaffirmed its 2025 sales outlook of $73.75 billion to $74.75 billion, maintaining its projected free cash flow of $6.6 billion to $6.8 billion. However, it sharply revised down its diluted earnings per share forecast to $21.70–$22.00 from a prior $27.00–$27.30. The revision reflects the heavy program losses and their lingering impact on segmental profitability.

The company’s backlog remains substantial at $166.5 billion, with significant contributions from Aeronautics ($52.2 billion), MFC ($40.3 billion), RMS ($38.6 billion), and Space ($35.5 billion). Management highlighted recent F-35 orders from allied nations, more than $1 billion in new U.S. Army missile contracts, and additional GPS IIIF satellite procurements from the U.S. Space Force as key indicators of sustained demand.

However, institutional investors remain cautious. Working capital pressures—primarily driven by increased receivables and contract assets tied to the F-35 program—are weighing heavily on cash flows. Free cash flow fell into negative territory this quarter for the first time in years, as production and invoice timing, Sikorsky helicopter inventory build-up, and slower billing cycles for national security space programs tightened liquidity.

Lockheed Martin Chairman and CEO Jim Taiclet attempted to reassure investors by emphasizing the company’s long-term growth drivers, which include hypersonics, integrated air and missile defense, and emerging space technologies. He reiterated that the charges taken this quarter were part of a “rigorous monitoring and review process” aimed at strengthening program execution. The company also maintained its capital allocation strategy, returning $1.3 billion to shareholders via dividends and share repurchases in the quarter.

What are analysts watching in Lockheed Martin’s next earnings, and how could program execution influence long-term valuation?

Market watchers believe the company’s ability to restore investor confidence will depend on demonstrating tangible improvements in program execution, particularly on high-profile classified contracts and helicopter programs. Timely deliveries and cost containment will be critical to reversing margin erosion and justifying Lockheed Martin’s premium valuation multiples relative to peers such as Northrop Grumman and General Dynamics.

Institutional investors are closely tracking the Aeronautics segment, which, despite the program loss, posted a 2% sales increase to $7.42 billion, largely due to higher F-35 production volume. Analysts argue that while demand for the F-35 remains strong globally, sustained working capital pressures and schedule risk could limit the segment’s cash conversion ratio in the coming quarters.

The RMS unit is also under scrutiny, as it represents a significant portion of the company’s international exposure. Analysts noted that resolving cost overruns and stabilizing contract performance on CMHP and TUHP will be essential to securing future international rotary-wing orders.

Despite near-term execution risks, defense budget stability and increasing geopolitical tensions continue to support Lockheed Martin’s long-term demand outlook. The ongoing U.S. Army missile contracts and strategic programs like the Next Generation Interceptor reinforce the company’s position as a critical supplier of next-generation deterrence technologies. Some institutional investors remain cautiously optimistic, citing Lockheed Martin’s strong positioning in missile defense and space-based systems.

Still, persistent free cash flow volatility could weigh on valuation. Analysts have warned that another quarter of negative cash flows might trigger a re-rating by investors, particularly those focused on dividend stability and buyback potential.